Cargando…
Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This seconda...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220517/ https://www.ncbi.nlm.nih.gov/pubmed/37234014 http://dx.doi.org/10.1001/jamahealthforum.2023.1127 |
_version_ | 1785049236692271104 |
---|---|
author | Persaud, Nav Bedard, Michael Boozary, Andrew Glazier, Richard H. Gomes, Tara Hwang, Stephen W. Jüni, Peter Law, Michael R. Mamdani, Muhammad Manns, Braden Martin, Danielle Morgan, Steven G. Oh, Paul Pinto, Andrew D. Shah, Baiju R. Sullivan, Frank Umali, Norman Thorpe, Kevin E. Tu, Karen Wu, Fangyun Laupacis, Andreas |
author_facet | Persaud, Nav Bedard, Michael Boozary, Andrew Glazier, Richard H. Gomes, Tara Hwang, Stephen W. Jüni, Peter Law, Michael R. Mamdani, Muhammad Manns, Braden Martin, Danielle Morgan, Steven G. Oh, Paul Pinto, Andrew D. Shah, Baiju R. Sullivan, Frank Umali, Norman Thorpe, Kevin E. Tu, Karen Wu, Fangyun Laupacis, Andreas |
author_sort | Persaud, Nav |
collection | PubMed |
description | IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial using a prespecified outcome took place across 9 primary care sites in Ontario, Canada (6 in Toronto and 3 in rural areas), where health care services are generally publicly funded. Adult patients (≥18 years old) reporting cost-related nonadherence to medicines in the past 12 months were recruited between June 1, 2016, and April 28, 2017, and followed up until April 28, 2020. Data analysis was completed in 2021. INTERVENTIONS: Access to a comprehensive list of 128 medicines commonly prescribed in ambulatory care with no out-of-pocket costs for 3 years vs usual medicine access. MAIN OUTCOME AND MEASURES: Total publicly funded health care costs over 3 years, including costs of hospitalizations. Health care costs were determined using administrative data from Ontario’s single-payer health care system, and all costs are reported in Canadian dollars with adjustments for inflation. RESULTS: A total of 747 participants from 9 primary care sites were included in the analysis (mean [SD] age, 51 [14] years; 421 [56.4%] female). Free medicine distribution was associated with a lower median total health care spending over 3 years of $1641 (95% CI, $454-$2792; P = .006). Mean total spending was $4465 (95% CI, −$944 to $9874) lower over the 3-year period. CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, eliminating out-of-pocket medication expenses for patients with cost-related nonadherence in primary care was associated with lower health care spending over 3 years. These findings suggest that eliminating out-of-pocket medication costs for patients could reduce overall costs of health care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02744963 |
format | Online Article Text |
id | pubmed-10220517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-102205172023-05-28 Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial Persaud, Nav Bedard, Michael Boozary, Andrew Glazier, Richard H. Gomes, Tara Hwang, Stephen W. Jüni, Peter Law, Michael R. Mamdani, Muhammad Manns, Braden Martin, Danielle Morgan, Steven G. Oh, Paul Pinto, Andrew D. Shah, Baiju R. Sullivan, Frank Umali, Norman Thorpe, Kevin E. Tu, Karen Wu, Fangyun Laupacis, Andreas JAMA Health Forum Original Investigation IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial using a prespecified outcome took place across 9 primary care sites in Ontario, Canada (6 in Toronto and 3 in rural areas), where health care services are generally publicly funded. Adult patients (≥18 years old) reporting cost-related nonadherence to medicines in the past 12 months were recruited between June 1, 2016, and April 28, 2017, and followed up until April 28, 2020. Data analysis was completed in 2021. INTERVENTIONS: Access to a comprehensive list of 128 medicines commonly prescribed in ambulatory care with no out-of-pocket costs for 3 years vs usual medicine access. MAIN OUTCOME AND MEASURES: Total publicly funded health care costs over 3 years, including costs of hospitalizations. Health care costs were determined using administrative data from Ontario’s single-payer health care system, and all costs are reported in Canadian dollars with adjustments for inflation. RESULTS: A total of 747 participants from 9 primary care sites were included in the analysis (mean [SD] age, 51 [14] years; 421 [56.4%] female). Free medicine distribution was associated with a lower median total health care spending over 3 years of $1641 (95% CI, $454-$2792; P = .006). Mean total spending was $4465 (95% CI, −$944 to $9874) lower over the 3-year period. CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, eliminating out-of-pocket medication expenses for patients with cost-related nonadherence in primary care was associated with lower health care spending over 3 years. These findings suggest that eliminating out-of-pocket medication costs for patients could reduce overall costs of health care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02744963 American Medical Association 2023-05-26 /pmc/articles/PMC10220517/ /pubmed/37234014 http://dx.doi.org/10.1001/jamahealthforum.2023.1127 Text en Copyright 2023 Persaud N et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Persaud, Nav Bedard, Michael Boozary, Andrew Glazier, Richard H. Gomes, Tara Hwang, Stephen W. Jüni, Peter Law, Michael R. Mamdani, Muhammad Manns, Braden Martin, Danielle Morgan, Steven G. Oh, Paul Pinto, Andrew D. Shah, Baiju R. Sullivan, Frank Umali, Norman Thorpe, Kevin E. Tu, Karen Wu, Fangyun Laupacis, Andreas Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title | Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title_full | Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title_fullStr | Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title_full_unstemmed | Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title_short | Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial |
title_sort | effect of free medicine distribution on health care costs in canada over 3 years: a secondary analysis of the clean meds randomized clinical trial |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220517/ https://www.ncbi.nlm.nih.gov/pubmed/37234014 http://dx.doi.org/10.1001/jamahealthforum.2023.1127 |
work_keys_str_mv | AT persaudnav effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT bedardmichael effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT boozaryandrew effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT glazierrichardh effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT gomestara effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT hwangstephenw effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT junipeter effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT lawmichaelr effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT mamdanimuhammad effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT mannsbraden effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT martindanielle effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT morgansteveng effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT ohpaul effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT pintoandrewd effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT shahbaijur effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT sullivanfrank effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT umalinorman effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT thorpekevine effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT tukaren effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT wufangyun effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial AT laupacisandreas effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial |